Lower Ts and Td baseline values in the BF were associated with a better performance and lower performance decrement in repeated sprint actions, respectively.
CGRP release was determined in pg/ml as absolute increase over baseline values in the corresponding two wells (CGRP levels after stimulation – baseline CGRP levels before stimulation).
The association of a decrease in blood counts from baseline values in the study population and the absorbed dose to the bone marrow was examined by analysis of variance (ANOVA) in linear regression analysis.
Urinary excretion rate of all the electrolytes assessed significantly increased as compared to baseline values only within the first 3 h (P < 0.05 vs. baseline values), returning toward baseline values in the subsequent hours.
PGE2 release was determined in pg/ml as absolute increase over baseline values in the corresponding two wells.
CGRP release was determined in pg/ml as absolute increase over baseline values in the corresponding two wells.
While myocardial function remained impaired compared to BL in the NT group (p<0.05), echocardiographic variables reached baseline values in the HT and HT+SEV group 24 hours after ROSC, respectively, and were significantly improved compared to NT (p<0.05 vs. NT, Figure 3).
Moreover, a temperature shift from 26°C to 18°C resulted in a significant reduction in SGCD transgene expression to baseline levels and concomitant improvement in cardiac function with a restoration of ESD, EDD, and FS to baseline values in the S151A- SGCD group.
PPEE was unchanged from baseline values in the glucose group (P = 0.86) (Table 3).
Baseline values in the experimental and control groups were no different.
Change over time was incorporated by inclusion of baseline values in the model.
